Excision
formerly Excision BioTherapeuticsSan Francisco, United States · Founded 2015 · $60.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- excision.bio
- Total Funding
- $60.0M
- Last Round
- GrantSep 2022
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Excision BioTherapeutics is a biopharmaceutical company developing in vivo CRISPR-Cas9 and CRISPR-CasX gene-editing therapies designed to cure viral infectious diseases rather than merely suppress them. Its lead candidate, EBT-101, targets latent HIV-1 reservoirs and builds on gene-editing research originated in the lab of Temple University professor Kamel Khalili. The company received FDA fast-track designation for EBT-101 in 2023 and advanced the therapy into early-stage human clinical trials, though a 2024 readout showed it did not maintain viral suppression alone at the initial dose.
Summary
Excision is a Biotech company based in San Francisco, United States, founded in 2015. It has raised $60.0M in total across 4 rounds, most recently a Grant round in Sep 2022. Investors include Artis Ventures (AV), GreatPoint Ventures and California Institute for Regenerative Medicine (CIRM).
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2022
Sign up to see all 4 events
Funding: Seed through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/excision"><img src="https://indexed.vc/api/badge/company/excision" alt="Excision on Indexed.vc" width="260" height="76" /></a>